Markets turned south again Wednesday as surging yields and geopolitical fears rattled investors, but Wall Street analysts spotted opportunity and danger in names like Baidu, Klarna, Honeywell Aerospace, and Dollar Tree that traders need to see before the open.

Aflac Incorporated (NYSE:AFL) has built an impressive dividend track record over the years. It has raised its dividend for 43 straight years, leaving the company just seven increases away from becoming a Dividend King, a milestone that requires 50 consecutive years of dividend growth. The company raised its quarterly dividend by 5.2% in early 2026 to […]

GL's premium growth, rising investment income and AI initiatives support earnings, while higher health claims remain a risk.

Aflac’s second quarter results were met with a negative market reaction, as sales declined year-over-year despite meeting Wall Street’s expectations. Management attributed the drop in revenue largely to tough comparisons in Japan following last year’s launch of the Miraito cancer insurance product, as well as shifting consumer preferences. CEO Daniel Amos emphasized that, while sales in Japan were down this quarter, new offerings like Tsumitasu and Anshin Palette produced solid growth. In the U.

AFL's growth in Japan and the U.S., disciplined expenses and strong premium persistency support the case for retaining the stock.

Japan sales fell 5.6% as pretax margins expanded 230 basis points.

Accident and health insurers face medical-cost pressures, but stronger underwriting, technology adoption and demand for supplemental coverage support growth.

Accident and Health Insurance stocks like AFL, GL, TRUP and EIG are set to gain from rising underwriting exposure and accelerated digitalization. However, pricing pressure is a concern given rising medical costs and inflation.

Supplemental insurance provider Aflac (NYSE:AFL) met Wall Street’s revenue expectations in Q2 CY2026, but sales fell by 6.9% year on year to $4.22 billion. Its non-GAAP profit of $1.75 per share was in line with analysts’ consensus estimates.

As Aflac Incorporated has lagged behind the SPX over the past year, Wall Street analysts maintain a cautious outlook about the stock’s prospects.

Aflac stock has delivered a strong 142.8% return over the past five years, yet current valuation checks send mixed signals, with the Excess Returns intrinsic value estimate pointing to upside while earnings based multiples lean the other way. A 142.8% gain over five years puts Aflac among the stronger long term performers, which raises the bar for any further upside from today's price. The share price can be supported if the company continues to convert earnings into steady cash flows...

Aflac (NYSE:AFL) reported second-quarter 2026 net earnings of $1.63 per diluted share and adjusted earnings of $1.75 per diluted share, as the insurer cited continued sales momentum in Japan and growth in its U.S. group insurance operations. Chief Financial Officer Max Brodén said adjusted earnings

Aflac Inc (AFL) reports adjusted EPS of $1.75, with Japan pretax margins up 230 basis points and a raised internal reinsurance target to 30% of FSA reserves.

Aflac's Q2 adjusted EPS misses estimates as lower investment income and FX weigh, but U.S. sales, policy persistency and capital returns offer support.

Moby summary of Aflac Incorporated's Q2 2026 earnings call

Although the revenue and EPS for Aflac (AFL) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Aflac (AFL) delivered earnings and revenue surprises of -1.13% and +0.89%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Supplemental insurance provider Aflac (NYSE:AFL) missed Wall Street’s revenue expectations in Q2 CY2026, with sales falling 9.2% year on year to $4.12 billion. Its non-GAAP profit of $1.75 per share was in line with analysts’ consensus estimates.

Trupanion (TRUP) delivered earnings and revenue surprises of +45.46% and +0.84%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

AFL appears best positioned for a Q2 earnings beat as favorable industry trends and a positive Earnings ESP set it apart from AIG and OSG.

AFL's improved Japan benefit-to-premium ratio may help offset premium and investment income pressure ahead of its Aug. 6 Q2 earnings report.

Evaluate the expected performance of Aflac (AFL) for the quarter ended June 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Humana has elected Paul Smith, Chief Commercial Officer at AI firm Anthropic, to its Board of Directors. The company has also elected Frederick Crawford, formerly President and COO at Aflac, to its Board. Both appointments add technology, insurance and financial expertise at the board level. Humana, traded as NYSE:HUM, is adding additional technology and insurance leadership at a time when its stock has seen a mix of gains and setbacks. The share price is $366.66, with the stock up 38.6%...

Aflac (AFL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Aflac (AFL) has attracted fresh attention as investors reassess the stock’s recent performance. The shares closed at $129.55, with returns over the past month, past 3 months, and year all in positive territory. See our latest analysis for Aflac. Recent trading has been strong, with Aflac’s 7.82% 1 month share price return and 17.52% year to date share price return feeding into a 31.24% 1 year total shareholder return. This suggests that momentum has been building rather than fading. If you...

Unum (UNM) delivered earnings and revenue surprises of +0.94% and +14.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

WTW's second quarter is likely to have benefited from strong performance across key businesses and international markets despite higher expenses.

UNM's Q2 results are expected to benefit from favorable persistency, stronger sales and growth across its key operating segments.

Some of the quietest stocks on Wall Street have been raising dividends for decades without missing a beat, and four financial sector names in particular have built a case for reliability that most headline-grabbing growth stocks cannot match.

Solid retention, renewals, prudent pricing, exposure growth and improved digitization are expected to help CINF, RGA, OSCR, WTW and AFL outperform Q2 estimates.

Aflac increased its first-quarter dividend 5.2%, but investors need to watch more than the dividend with this unique insurance company.

Aflac is set to report Q2 earnings, and Wall Street expects its earnings to fall marginally.

Unum Group's premium growth, technology investments and capital returns support long-term growth, though pricing pressure and higher expenses remain risks.

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajectories fall.

Oxford Club strategist Marc Lichtenfeld highlights diversification beyond tech, spotlighting Ligand Pharmaceuticals, Aflac and Atlantic Union Bankshares as healthcare, insurance and banking stocks gaining quiet momentum.